Stonepine Capital Management, LLC and Affiliates File Schedule 13G for Kezar Life Sciences, Inc.

Stonepine Capital Management, LLC, along with its affiliates Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico, have filed a Schedule 13G with the SEC regarding their ownership of Kezar Life Sciences, Inc. The filing indicates that these entities collectively own 377,240 shares of Kezar Life Sciences' common stock, representing approximately 5.2% of the outstanding shares. The shares are held by Stonepine Capital, L.P. for the benefit of its investors. The filing also includes an agreement regarding the joint filing of statements on Schedule 13D or 13G, appointing Stonepine Capital Management, LLC as the agent and attorney-in-fact for the purpose of filing such statements. The filing was made under Rule 13d-1(c) and includes certifications that the securities were not acquired for the purpose of influencing the control of the issuer.